-
Signature
-
/s/ Tobin Schilke, as attorney-in-fact
-
Issuer symbol
-
CRNX
-
Transactions as of
-
26 Sep 2025
-
Transactions value $
-
-$180,000
-
Form type
-
4
-
Filing time
-
30 Sep 2025, 16:42:56 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Struthers Richard Scott |
President & CEO, Director |
C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO |
/s/ Tobin Schilke, as attorney-in-fact |
30 Sep 2025 |
0001746298 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRNX |
Common Stock |
Sale |
-$180,000 |
-4,000 |
-3.6% |
$45 |
106,000 |
26 Sep 2025 |
By Family Trust 2 |
F1, F2 |
| holding |
CRNX |
Common Stock |
|
|
|
|
|
320,017 |
26 Sep 2025 |
Direct |
|
| holding |
CRNX |
Common Stock |
|
|
|
|
|
661,205 |
26 Sep 2025 |
By Family Trust 1 |
|
| holding |
CRNX |
Common Stock |
|
|
|
|
|
110,000 |
26 Sep 2025 |
By Family Trust 3 |
|
| holding |
CRNX |
Common Stock |
|
|
|
|
|
100,000 |
26 Sep 2025 |
By Family Trust 4 |
|
| holding |
CRNX |
Common Stock |
|
|
|
|
|
1,000 |
26 Sep 2025 |
By Spouse |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: